Miyako Kojo
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy.
Journal: Anticancer research
Published: July 02, 2014
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: June 05, 2014
Dramatic response to crizotinib in an ALK-positive adenocarcinoma patient with disseminated intravascular coagulation.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 17, 2013
Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Journal: Japanese journal of clinical oncology
Published: August 07, 2013
The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 21, 2013
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Journal: International journal of clinical oncology
Published: April 10, 2013
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 08, 2013
Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: A case report.
Journal: Oncology letters
Published: December 23, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026